Abstract

SPARTA® - Enabling Nanoformulations For Next-Generation Therapeutics

Jelle Penders, CEO & CTO, SPARTA Biodiscovery Ltd.

SPARTA^® (Single Particle Automated Raman Trapping Analysis) is a cutting-edge benchtop instrument that chemically analyses and characterizes single nanoparticles in a fully automated, high-throughput, non-destructive label-free process. Dr. Penders will talk through the benefits of this technique for nanoformulation research as well as industry applications and show the breath of data that can be acquired and analyzed.